Held at the Johns Hopkins Bloomberg Center in Washington, DC, the 2024 symposium welcomed ~ 103 attendees who shared insights and assessed progress. It charted a collective course of action to combat the threat posed by substandard and falsified drugs. Through enlightening keynote addresses and interactive discussions, the event emphasized Read more…
Issue 5 of SF Pulse is out now! The issue highlights the following: A call to World Health Organization to expand its existing Prequalification of Medicines Programme, which helps ensure enforcement of quality standards for a wide range of medical products. How counterfeiters are now successfully replicating packaging QR codes Read more…
Geneva, Switzerland | February 26, 2025 The Fight the Fakes Alliance is excited to extend the warmest welcome to Fondation Pierre Fabre and the Italian Center for Coordinated Research (CRC) in Precision Medicine and Chronic Inflammation at the University of Milan as our newest members, as of January 2025. These Read more…
This statement was delivered by the World Heart Federation on behalf of Fight the Fakes Alliance at the 156th session of the WHO Executive Board: Honourable Chair, Distinguished Delegates, The World Heart Federation, supported by the Fight the Fakes Alliance, welcomes the independent evaluation of the Member State Mechanism on Read more…
Issue 4 of SF Pulse is out now! The newest issue dives into five topics including: A deep dive into how Johnson & Johnson starts thinking about anti-counterfeiting needs well before the product launch. An article by the Global Initiative Against Transnational Organized Crime highlighting the risks that an increased Read more…
On October 3rd, FTFA was invited by the World Trade Organization to speak at a closed-door panel discussion about “Substandard, Falsified and Counterfeit Medical Products” alongside the World Health Organization and the World Customs Organization. The event brought together country representatives from 30+ countries in the context of WTO’s annual Read more…
The Global Pharma Health Fund (GPHF), a non-profit organization supported by Merck KGaA, is pleased to announce the Special Edition 2024, featuring a new Minilab test for detecting the toxic antifreeze agents diethylene glycol (DEG) and ethylene glycol (EG). The GPHF-Minilab is a portable mini-laboratory designed to detect substandard, falsified, and adulterated medicines, especially Read more…
September 24, 2024, Location – Fight the Fakes Alliance is excited to announce and welcome the Université la Source Conakry as the newest member of the Alliance. Given that one-fifth of medicines in Africa are potentially substandard or falsified (SFs), and that SFs in sub-Saharan kill almost 500,000 people each Read more…
Medical Product Alert N°3/2024: Falsified (contaminated) Oxymorphone Hydrochloride 40mg Alert Summary This WHO Medical Product Alert refers to one batch of falsified Oxymorphone Hydrochloride 40mg. The falsified product was detected in the unregulated supply chain in Finland and reported to WHO in July 2024 by the Finnish Medicines Agency (FIMEA). Read more…
On July 31st, 24, BBC published an article on the devastating effects surrounding the online purchases of fake semaglutide – an active ingredient in legal drugs like Ozempic, a type 2 diabetes drug, and Wegovy, a weight loss drug. The article interviewed a member of Fight the Fakes Alliance, Oksana Read more…